AMRX R&D Expenses
Amneal Pharmaceuticals Inc Class A · R&D Expenses
AMRX R&D Expenses
Latest reported$177.66Mperiod ending
AMRX TTM R&D Expenses ($185.77M → $177.66M)
TTM R&D Expenses
High-resolution chart · PNG
AMRX r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 177,658,000 | |
| 186,535,000 | |
| 189,959,000 | |
| 211,257,000 | |
| 209,002,000 | |
| 196,117,000 | |
| 193,608,000 | |
| 184,055,000 | |
| 165,219,000 | |
| 166,742,000 | |
| 167,778,000 | |
| 164,483,000 | |
| 173,868,000 | |
| 186,818,000 | |
| 200,046,000 | |
| 209,793,000 | |
| 208,701,000 | |
| 211,361,000 | |
| 209,563,000 | |
| 213,708,000 | |
| 209,807,000 | |
| 204,700,000 | |
| 190,585,000 | |
| 186,449,000 | |
| 180,507,000 | |
| 181,912,000 | |
| 202,287,000 | |
| 209,796,000 | |
| 216,485,000 | |
| 220,340,000 | |
| 211,101,000 | |
| 196,793,000 | |
| 197,409,000 | |
| 195,137,000 | |
| 185,771,000 | |
| 183,058,000 |